Tech Company Financing Transactions
Averto Medical Funding Round
Cormorant Asset Management, CVF and LifeSci Venture Partners participated in a $30 million Series A funding round for Averto Medical. This venture round was announced on 5/7/2024.
Transaction Overview
Company Name
Announced On
5/7/2024
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to support the growth of its clinical testing of the ColoSeal� intraluminal diversion system towards regulatory approvals.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
871 Corporate Way
Fremont, CA 94539
USA
Fremont, CA 94539
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Averto Medical is a privately held clinical stage medical technology company focused on solutions for patients suffering from gastrointestinal diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kenton Fong
Chief Operating Officer
Dean Hu
VP - Engineering
Jeffrey Etter
VP - Regulatory Affairs
Grace Carlson
Browse more venture capital transactions:
Prev: 5/7/2024: everyone energy venture capital transaction
Next: 5/7/2024: Rad AI venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs